Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-02

Clinical Trial Update: rTMS for the Treatment of Affective Symptoms in Patients Suffering From Dementia [Phase 4]

View source ↗

Summary

Phase 4 trial exploring repetitive transcranial magnetic stimulation (rTMS) for affective symptoms in dementia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RTMS (Repetitive transcranial magnetic stimulation)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Behavioral and Psychiatric Symptoms of Dementia | Phase 4 | Status: UNKNOWN